Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K242035
    Manufacturer
    Date Cleared
    2024-10-11

    (91 days)

    Product Code
    Regulation Number
    878.4810
    Reference & Predicate Devices
    N/A
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Accure Laser System is indicated for the long-term treatment of mild to severe inflammatory acne vulgars.

    Device Description

    Not Found

    AI/ML Overview

    The provided FDA 510(k) clearance letter for the "Accure Laser System" does not contain any information regarding acceptance criteria or a study that proves the device meets those criteria.

    This document is a letter from the FDA stating that they have reviewed the 510(k) premarket notification and determined the device is substantially equivalent to legally marketed predicate devices. It outlines regulatory requirements and general information about FDA processes but does not detail the specific performance studies or data used to support the substantial equivalence claim.

    Therefore, I cannot provide the requested information based solely on the provided text. To answer your questions, additional documentation, such as the actual 510(k) summary or a clinical study report, would be needed.

    Ask a Question

    Ask a specific question about this device

    K Number
    K222109
    Device Name
    Accure Laser
    Manufacturer
    Date Cleared
    2022-11-17

    (122 days)

    Product Code
    Regulation Number
    878.4810
    Reference & Predicate Devices
    N/A
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Accure Laser System is indicated for the treatment of mild to severe inflammatory acne vulgaris.

    Device Description

    Not Found

    AI/ML Overview

    The provided text is a 510(k) premarket notification letter from the FDA regarding the Accure Laser System. It does not contain any information about acceptance criteria or a study that proves the device meets specific performance criteria, especially not in the context of an AI/ML powered device, which is implied by the detailed questions about ground truth, training sets, and human-in-the-loop performance.

    The document discusses:

    • The FDA's determination of substantial equivalence to a predicate device.
    • The regulatory classification (Class II, Product Code GEX).
    • General controls provisions of the Act that apply to the device.
    • Indications for Use (treatment of mild to severe inflammatory acne vulgaris).

    Therefore, I cannot answer the specific questions about acceptance criteria, study details, sample sizes, expert qualifications, or ground truth establishment based on the provided text. The device described, the Accure Laser System, appears to be a hardware laser system, not an AI/ML-powered diagnostic or treatment device.

    If you have information about a study or acceptance criteria for an AI/ML device related to this, please provide that text for analysis.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1